The management of Vaginal intraepithelial neoplasia (VaIN)

Maha Gurumurthy, Maggie Cruickshank

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

OBJECTIVES: Vaginal intraepithelial neoplasia (VaIN) accounts for 0.4% of the lower genital tract intraepithelial disease. Various treatments have been reported often as small case series or reports.

MATERIALS AND METHODS: An electronic search of the Ovid MEDLINE (from 1948 to present) and PubMed was performed, and only articles written in English were reviewed. All articles ranging from case reports to randomized controlled trials were included. This review critically appraises the published evidence for different treatment modalities and gives an overview of these options.

RESULTS: The 3 main modalities reported were surgery, brachytherapy, and medical management. Surgery included local excision, laser ablation, vaginectomy, and cavitational ultrasonic ablation. Medical management included topical 5% imiquimod, 5-fluorouracil, and tricholoroacetic acid. All treatments had good success rates for disease clearance with low rates of progression to cancer. Prerequisites for ablative treatments are the lesion is fully visible and adequately examined by biopsy to exclude invasion. Where invasion is suspected or cannot be excluded (e.g., at the vault suture line), surgical excision is essential. Brachytherapy and vaginectomy, although effective, have a limited place because of their related morbidity. Treatment choice may depend on the availability of equipment and expertise.

CONCLUSIONS: Conservative options in the form of laser ablation and topical agents are useful as first-line treatment methods especially in young women and for multifocal disease. Radical options like brachytherapy and vaginectomy should be reserved for highly selected cases. Evidence from a randomized controlled trial of first-line treatment with surgical and medical therapies is needed to compare treatment success and impact on quality of life.

Original languageEnglish
Pages (from-to)306-312
Number of pages7
JournalJournal of Lower Genital Tract Disease
Volume16
Issue number3
DOIs
Publication statusPublished - Jul 2012

Fingerprint

Neoplasms
Brachytherapy
Therapeutics
Laser Therapy
imiquimod
Randomized Controlled Trials
PubMed
Ultrasonics
MEDLINE
Fluorouracil
Sutures
Quality of Life
Morbidity
Biopsy
Equipment and Supplies
Acids

Keywords

  • VaIN
  • colposscopy

Cite this

The management of Vaginal intraepithelial neoplasia (VaIN). / Gurumurthy, Maha; Cruickshank, Maggie.

In: Journal of Lower Genital Tract Disease, Vol. 16, No. 3, 07.2012, p. 306-312.

Research output: Contribution to journalArticle

@article{34dcd25ab2c94ccdbd62bf0e31504682,
title = "The management of Vaginal intraepithelial neoplasia (VaIN)",
abstract = "OBJECTIVES: Vaginal intraepithelial neoplasia (VaIN) accounts for 0.4{\%} of the lower genital tract intraepithelial disease. Various treatments have been reported often as small case series or reports. MATERIALS AND METHODS: An electronic search of the Ovid MEDLINE (from 1948 to present) and PubMed was performed, and only articles written in English were reviewed. All articles ranging from case reports to randomized controlled trials were included. This review critically appraises the published evidence for different treatment modalities and gives an overview of these options. RESULTS: The 3 main modalities reported were surgery, brachytherapy, and medical management. Surgery included local excision, laser ablation, vaginectomy, and cavitational ultrasonic ablation. Medical management included topical 5{\%} imiquimod, 5-fluorouracil, and tricholoroacetic acid. All treatments had good success rates for disease clearance with low rates of progression to cancer. Prerequisites for ablative treatments are the lesion is fully visible and adequately examined by biopsy to exclude invasion. Where invasion is suspected or cannot be excluded (e.g., at the vault suture line), surgical excision is essential. Brachytherapy and vaginectomy, although effective, have a limited place because of their related morbidity. Treatment choice may depend on the availability of equipment and expertise. CONCLUSIONS: Conservative options in the form of laser ablation and topical agents are useful as first-line treatment methods especially in young women and for multifocal disease. Radical options like brachytherapy and vaginectomy should be reserved for highly selected cases. Evidence from a randomized controlled trial of first-line treatment with surgical and medical therapies is needed to compare treatment success and impact on quality of life.",
keywords = "VaIN, colposscopy",
author = "Maha Gurumurthy and Maggie Cruickshank",
year = "2012",
month = "7",
doi = "10.1097/LGT.0b013e31823da7fb",
language = "English",
volume = "16",
pages = "306--312",
journal = "Journal of Lower Genital Tract Disease",
issn = "1089-2591",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - The management of Vaginal intraepithelial neoplasia (VaIN)

AU - Gurumurthy, Maha

AU - Cruickshank, Maggie

PY - 2012/7

Y1 - 2012/7

N2 - OBJECTIVES: Vaginal intraepithelial neoplasia (VaIN) accounts for 0.4% of the lower genital tract intraepithelial disease. Various treatments have been reported often as small case series or reports. MATERIALS AND METHODS: An electronic search of the Ovid MEDLINE (from 1948 to present) and PubMed was performed, and only articles written in English were reviewed. All articles ranging from case reports to randomized controlled trials were included. This review critically appraises the published evidence for different treatment modalities and gives an overview of these options. RESULTS: The 3 main modalities reported were surgery, brachytherapy, and medical management. Surgery included local excision, laser ablation, vaginectomy, and cavitational ultrasonic ablation. Medical management included topical 5% imiquimod, 5-fluorouracil, and tricholoroacetic acid. All treatments had good success rates for disease clearance with low rates of progression to cancer. Prerequisites for ablative treatments are the lesion is fully visible and adequately examined by biopsy to exclude invasion. Where invasion is suspected or cannot be excluded (e.g., at the vault suture line), surgical excision is essential. Brachytherapy and vaginectomy, although effective, have a limited place because of their related morbidity. Treatment choice may depend on the availability of equipment and expertise. CONCLUSIONS: Conservative options in the form of laser ablation and topical agents are useful as first-line treatment methods especially in young women and for multifocal disease. Radical options like brachytherapy and vaginectomy should be reserved for highly selected cases. Evidence from a randomized controlled trial of first-line treatment with surgical and medical therapies is needed to compare treatment success and impact on quality of life.

AB - OBJECTIVES: Vaginal intraepithelial neoplasia (VaIN) accounts for 0.4% of the lower genital tract intraepithelial disease. Various treatments have been reported often as small case series or reports. MATERIALS AND METHODS: An electronic search of the Ovid MEDLINE (from 1948 to present) and PubMed was performed, and only articles written in English were reviewed. All articles ranging from case reports to randomized controlled trials were included. This review critically appraises the published evidence for different treatment modalities and gives an overview of these options. RESULTS: The 3 main modalities reported were surgery, brachytherapy, and medical management. Surgery included local excision, laser ablation, vaginectomy, and cavitational ultrasonic ablation. Medical management included topical 5% imiquimod, 5-fluorouracil, and tricholoroacetic acid. All treatments had good success rates for disease clearance with low rates of progression to cancer. Prerequisites for ablative treatments are the lesion is fully visible and adequately examined by biopsy to exclude invasion. Where invasion is suspected or cannot be excluded (e.g., at the vault suture line), surgical excision is essential. Brachytherapy and vaginectomy, although effective, have a limited place because of their related morbidity. Treatment choice may depend on the availability of equipment and expertise. CONCLUSIONS: Conservative options in the form of laser ablation and topical agents are useful as first-line treatment methods especially in young women and for multifocal disease. Radical options like brachytherapy and vaginectomy should be reserved for highly selected cases. Evidence from a randomized controlled trial of first-line treatment with surgical and medical therapies is needed to compare treatment success and impact on quality of life.

KW - VaIN

KW - colposscopy

U2 - 10.1097/LGT.0b013e31823da7fb

DO - 10.1097/LGT.0b013e31823da7fb

M3 - Article

VL - 16

SP - 306

EP - 312

JO - Journal of Lower Genital Tract Disease

JF - Journal of Lower Genital Tract Disease

SN - 1089-2591

IS - 3

ER -